Page 118 - MemoriaCIBER2019-ENG
P. 118
118
CIBER Annual report 2019
P3. Biological behavioural
and structural determinants in the contraction and spread of communicable diseases in vulnerable populations (DAPET Programme)
Coordinator: Juan Carlos Galán Montemayor* (*Until November the coordinator was Dr. Jordi Casabona)
Immigration and Health Subprogramme:
Projects:
• Gilead Sciences “HepC-link“ Pilot hepatitis C micro-elimination strategy in Pakistani immigrants in Catalo-
nia through the implementation of a community intervention” (PI: Dr. Casabona).
• FIS “Cost-effectiveness of a community intervention versus a strategy based on the healthcare system to promote the prevention, diagnosis and treatment of hepatitis B and C in immigrants in Catalonia” (PI: Dr. Casabona).
• Ibero-american Network of Pneumocystis in pregnant women and newborns (PI: Dr. Calderón).
• Project “ERANet-LAC: ELAC2014/HID0254 “Recognition of the primary infection by Pneumocystis in infants:
a silent threat to public health”. (PIs: Dr. Moya and Dr. Calderón).
• Project “Study of new recombinant forms of HIV in the sub-Saharan population” (PIs: Dr. Galán and Dr.
Moya). Publications:
• Int. J. Environ. Res. Public Health 2019, 16(11), 2027;
• Int. J. Environ. Res. Public Health 2019, 16(10), 1796;
• Int. J. Environ. Res. Public Health 2019, 16(7), 1288
• Safety Science, 2019 115, 36-41
• Gac Sanit, 2019 (in press).
• Front Public Health. 2019 Oct 15;7:292.
• Front Public Health. 2019 Oct 9;7:289.
• Front Public Health. 2019 Oct 4;7:275.
• Clin Epidemiol. 2019 Jul 22;11:615-624.
• OBM Genetics volume 3, issue 1. 10.21926/obm.genet.1901066
Communicable infections through organic fluids Subprogramme:
Projects:
• “Determinants and needs of sexual health in a multicentre cohort of transgender men and women acting as sex workers in Barcelona and Madrid-Sexcohort” PI18/01481 (PIs: Dr. Casabona and Dr. Alemany).
• FIS Project “Selection of a panel of sera from patients with recent infection in the Hospital Ramón y Cajal for the comparison of the efficacy of early detection and/or quantification of HIV of various serological and molecular techniques currently available or under development” (PI: Dr. Galán).
• Gilead Grants “ReHCV - Molecular epidemiology study of HCV reinfection in the Catalan Penitentiary Sys- tem” (PI: Dr. Casabona).
• Evaluation of the Xpert HCV Viral Load point-of-care assay from capillary blood in people who inject drugs(PI: Dr. Casabona).